Sign-up for the third webinar in a 6-part series, titled, “Addressing the High Cost of Radiology Services.”

T​his webinar will highlight how community cancer programs are using a new approach to optimize biomarker testing processes through the addition of a precision medicine steward.

A webinar featuring Dr. Randall Oyer, Dr. Lori Pierce, Sanford Jeames, and Leila Hamroun, discussing the ASCO-ACCC joint collaboration, dissemination of the site self assessment and training program.

Sign-up for the second in a 6-part series, titled, “Proactive Interventions for the Prior Authorization Process”

Raise awareness among cancer programs of new treatment options for newly diagnosed patients with multiple myeloma ineligible for transplant.

Oncology state society leaders from the Appalachian Community Cancer Alliance share an introduction to the Alliance, their insights into the unique needs of the Appalachian region and beyond, how the Alliance is responding and how you can get involved.

This educational initiative will focus on multidisciplinary education surrounding TILs, with an emphasis on the importance of implementing clinical trials in the community setting.

The COVID-19 pandemic has affected treatment patterns for patients with CLL. Javier Munoz, MD, MS, FACP, Senior Associate Consultant in the Division of Hematology and Medical Oncology at the Mayo Clinic (Arizona) will discuss considerations for treating patients with CLL in the pandemic--including options for treatment, best timing for treatment, and any changes to the usual treatment regimen. Dr. Munoz will also explore what care may look like for patients with CLL beyond COVID-19.

The COVID-19 pandemic has heightened the distress patients with CLL are experiencing and taken its toll on providers. In this presentation, Alison Mayer Sachs, MSW, LSW, OSW-C, FAOSW, Director of Community Outreach & Cancer Support Services in the Eisenhower Lucy Curci Cancer Center at Eisenhower Medical Center will discuss the distress experienced by both patients and providers and offer solutions and ways forward.

The speaker will discuss considerations around the COVID-19 vaccines and interpret the respective NCCN guidance for patients with CLL and other cancers.